Zenas BioPharma, Inc. (ZBIO)
Zenas BioPharma Market Cap: 1.594B for Dec. 4, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Royalty Pharma Plc | 16.73B |
| Amgen, Inc. | 183.17B |
| Merck & Co., Inc. | 250.41B |
| Bristol Myers Squibb Co. | 105.76B |
| Aquestive Therapeutics, Inc. | 785.70M |
Market Cap Related Metrics
| PS Ratio | 106.47 |
| PEG Ratio | -0.0549 |
| Price to Book Value | 8.116 |
| Price | 38.11 |
| Earnings Yield | -11.89% |
| PEGY Ratio | -0.0549 |